| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 02/20/2003 | WO2002092758A8 Gastrokines and derived peptides including inhibitors |
| 02/20/2003 | WO2002086085A3 Human timp-1 antibodies |
| 02/20/2003 | WO2002083849A3 Vascular endothelial growth factor 2 |
| 02/20/2003 | WO2002079396A3 Biological carriers for induction of immune responses |
| 02/20/2003 | WO2002069904A3 Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| 02/20/2003 | WO2002062850A3 Hybrid antibodies and uses thereof |
| 02/20/2003 | WO2002061057A3 Regulation of human wee1-like serine/threonine protein kinase |
| 02/20/2003 | WO2002057307A3 Genes |
| 02/20/2003 | WO2002052012A8 Sugar beet genes involved in stress tolerance |
| 02/20/2003 | WO2002051351A3 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 02/20/2003 | WO2002047730A8 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 02/20/2003 | WO2002027322A9 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 02/20/2003 | WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells |
| 02/20/2003 | US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies |
| 02/20/2003 | US20030036645 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 02/20/2003 | US20030036634 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036633 DNA encoding bradykinin B1 receptor |
| 02/20/2003 | US20030036632 Protein for use in the treatment of alzheimer's, muscle, nervous system and thrombocytopenia |
| 02/20/2003 | US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects |
| 02/20/2003 | US20030036630 Nucleotide sequences for use in human therapeutics and diagnostics |
| 02/20/2003 | US20030036507 Urocortin-III and uses thereof |
| 02/20/2003 | US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides |
| 02/20/2003 | US20030036182 Blocked immunoglobulin comprising antibody portion having heavy or light chain variable region; and Protein A portions; tethered to solid support; antibody sandwich, enzyme-linked immunosorbent, antibody dipstick, antibody microarray, radioimmuno-, or rolling circle amplification assay |
| 02/20/2003 | US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036178 Long wavelength engineered fluorescent proteins |
| 02/20/2003 | US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 02/20/2003 | US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036168 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/20/2003 | US20030036167 Protease proteins that are related to the choriolytic hatching protease subfamily, recombinant DNA molecules, and protein production. |
| 02/20/2003 | US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/20/2003 | US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036114 Nucleotide sequences coding polyopeptide for use in the diagnosis and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036113 Regulatory nucleotide sequences for use as tools in genetic engineering |
| 02/20/2003 | US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 02/20/2003 | US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins |
| 02/20/2003 | US20030036102 Cathepsin differentially expressed in lung cancer |
| 02/20/2003 | US20030036100 Simultaneous determination of phenotype and genotype |
| 02/20/2003 | US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders |
| 02/20/2003 | US20030036092 Directed evolution of enzymes and antibodies |
| 02/20/2003 | US20030036074 Novel nucleic acid sequences encoding human transporters, a human atpase molecule, a human ubiquitin hydrolase-like molecule, a human ubiquitin conjugating enzyme-like molecule, and uses therefor |
| 02/20/2003 | US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders |
| 02/20/2003 | US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030035816 Soluble ctla4 mutant molecules and uses thereof |
| 02/20/2003 | US20030035815 Recombitope peptides |
| 02/20/2003 | US20030035809 Nucleic acids; veterinary medicine |
| 02/20/2003 | US20030035807 Self antigen vaccines for treating B cell lymphomas and other cancers |
| 02/20/2003 | US20030035803 Nervous system disorders; autoimmune diseases; anticancer agents |
| 02/20/2003 | US20030035802 Angiogenosis inhibitors; antitumor, anticancer agents |
| 02/20/2003 | US20030035800 Glycosylated humanized B-cell specific antibodies |
| 02/20/2003 | US20030035799 Glycosylated antibody |
| 02/20/2003 | US20030035798 Prevention infections; such as colds, influenza |
| 02/20/2003 | US20030035797 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 02/20/2003 | US20030035796 Novel compound for treatment of allergy and asthma |
| 02/20/2003 | US20030035793 Novel immune response targeting molecules |
| 02/20/2003 | US20030035790 Anticancer agents, antinflamamtory agents, infection therapy |
| 02/20/2003 | US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | CA2763913A1 Antigen binding domains |
| 02/20/2003 | CA2459071A1 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 02/20/2003 | CA2456928A1 Cellular virus receptors and methods of use |
| 02/20/2003 | CA2456786A1 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | CA2456723A1 Inhibitors of her3 activity |
| 02/20/2003 | CA2456571A1 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | CA2456369A1 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | CA2456287A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 02/20/2003 | CA2456247A1 Use of il-18 inhibitors in hypersensitivity disorders |
| 02/20/2003 | CA2456236A1 Methods of screening based on the egf receptor crystal structure |
| 02/20/2003 | CA2456121A1 Intracellular antibodies |
| 02/20/2003 | CA2456010A1 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2428822A1 Modulators of p-selectin glycoprotein ligand 1 |
| 02/19/2003 | EP1284288A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 02/19/2003 | EP1283889A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/19/2003 | EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283869A2 Novel bee venom polypeptides and methods of use thereof |
| 02/19/2003 | EP1283868A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 02/19/2003 | EP1283851A2 Use of interleukin-4 antagonists and compositions thereof |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283722A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1283720A1 Recombinant or purified polyclonal antibodies for treating allergy |
| 02/19/2003 | EP1283719A2 Apoptotic agents |